MX1 and rheumatoid arthritis: This hypothesis-generating study identified MX1, OASL, SPINK1, CRK, GRAPL and RNF2 as novel targets for RA therapeutic intervention, and the PLS model based on their expression levels may have the potential prognostic value in RA patients who are treated with TG tablets.